The Most Important Healthcare and Life Science Deals Of 2025

Mike Riella was quoted in a Law360 article highlighting the most important healthcare and life sciences deals of 2025. Mike commented on Pfizer’s $10 billion agreement to buy Metsera, stating that the bidding war was a fascinating period for M&A attorneys like himself.

While Pfizer ultimately won the battle, Mike said he's watching to see how the unique deal structure that Novo offered may affect future transactions and structures.

If others attempt to implement a similar type of deal in the coming years, the industry may at one point receive "real FTC feedback on whether that transaction structure actually works," he said.